Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2026 · 10-Q
Revenue$27.80M$27.80M+18.6% vs Q1 2025 Net Income$458.96K$458.96KN/M vs Q1 2025 EPS Diluted$0.05$0.05N/M vs Q1 2025 Gross Profit$25,874,945+19.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$2,465,407N/M Free Cash Flowderived-$2,509,179N/M Margins · derivedGross margin93.1%+0.9 pt vs Q1 2025
Operating margin9.5%+6.0 pt vs Q1 2025
Net margin1.7%+16.7 pt vs Q1 2025
ended Mar 31, 2026 · filed May 12, 2026 · 42 d after period end